The effects of lithium on the thyroid gland;Lithiumwirkungen auf die Schilddruse

Nervenheilkunde

Volumn 17, Issue 3, 1998, Pages 114-119

  Leutgeb, U ^a  

^a NONE   (Germany)

Author keywords

Goiter; Hyperthyroidism; Hypothyroidism; Lithium

Indexed keywords

LEVOTHYROXINE; LITHIUM; RADIOACTIVE IODINE;

DEPRESSION; DRUG INDUCED DISEASE; GOITER; HORMONE SUBSTITUTION; HUMAN; HYPERTHYROIDISM; HYPOTHYROIDISM; MENTAL DISEASE; PRACTICE GUIDELINE; PSYCHOPHARMACOTHERAPY; RADIOISOTOPE THERAPY; REVIEW; THYROID DISEASE;

EID: 0031874355     PISSN: 07221541     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (68)

1. Albrecht J, Hopf U. Humorale Autoimmunphänomene unter Langzeittherapie mit Lithium unter besonderer Berücksichtigung schilddrüsenspezifischer Autoantikörper. Klin Wschr 1982; 60: 1501-4.
2. Barclay ML, Brownlie BEW, Turner JG, Wells JE. Lithium associated thyrotoxicosis: a report of 14 cases, with statistical analysis of incidence. Clin Endocrinol 1994; 40: 759-64.
3. Baumgartner A, v. Stuckrad M, Müller-Oerlinghausen B et al. The hypothalamic-pituitary-thyroid axis in patients maintained on lithium prophylaxis for years: high triiodothyronine serum concentrations are correlated to the prophylactic efficacy. J Affect Dis 1995; 34: 211-8.
4. Becerra-Fernandez A. Autoimmune thyrotoxicosis during lithium therapy in a patient with manic-depressive illness. Am J Med 1995; 99: 575.
5. Benkert O, Hippius H. Psychiatrische Pharmakotherapie. Berlin, Heidelberg, New York: Springer 1996.
6. Bocchetta A, Bernardi F, Burrai C et al. The course of thyroid abnormalities during lithium treatment: A two-year follow-up study. Acta Psychiat Scand 1992; 86: 38-41.
7. Bocchetta A, Bernardi F, Pedditzi M et al. Thyroid abnormalities during lithium treatment. Acta Psychiat Scand 1991; 83: 193-8.
8. Bocchetta A, Chercha A, Loviselli A et al. Six-year follow-up of thyroid function during lithium treatment. Acta Psychiat Scand 1996; 94: 45-8.
9. Brogmus KE, Winiarski B. Lithium und Hyperthyreose. Psychiat Prax 1993; 20: 74-7.
10. Brownlie BEW, Chambers ST, Sadler WA, Donald RA. Lithium associated thyroid disease - a report of 14 cases of hypothyroidism and 4 cases of thyrotoxicosis. Aust NZ J Med 1976; 6: 223-9.
11. Bürgi U, Gerber H, Studer H. Goitrogenesis in iodine deficiency. In: Iodine deficiency in Europe. Delange F, Dunn JT, Glinoer D. (eds). New York, London: Plenum Press 1993; 61-7.
12. Calabrese JR, Gulledge AD, Hahn K et al. Autoimmune thyroiditis in manic-depressive patients treated with lithium. Am J Psychiat 1985; 142: 1318-21.
13. Custro N, Scafidi V, Lo Baido R et al. Subclinical hypothyroidism resulting from autoimmune thyroiditis in female patients with endogenous depression. J Endocrinol Invest 1994; 17: 641-6.
14. Dussault JH. Iodine intake in Canada. In: Iodine deficiency in Europe. Delange F, Dunn JT, Glinoer D. (eds). New York, London: Plenum Press 1993; 131.
15. Felber W, König L. Die Lithiumstruma und ihre psychiatrische Relevanz. Psychiat Prax 1988; 15: 57-61.
16. Feldkamp J, Seppel T, Santen R et al. Jodid versus Levothyroxin bei endemischer Struma: Ergebnisse einer Studie bei älteren Patienten. In: Schilddrüse 1995. Schilddrüsenerkrankungen in verschiedenen Lebensabschnitten. Usadel KH, Weinheimer B (Hrsg). Berlin, New York: W de Gruyter 1996; 366-70.
17. Gärtner R. Struma - Pathophysiologie und Definition des Krankheitsbildes. In: Struma. Köbberling J, Pickardt CR (Hrsg). Berlin, Heidelberg, New York: Springer 1990; 7-13.
18. Gutekunst R, Smolarek H, Hasenpusch U et al. Goitre epidemiology: Thyroid volume, iodine excretion, thyroglobulin and thyrotropin in Germany and Sweden. Acta Endocrinol 1986; 112: 494-501.
19. Haggerty JJ, Prange AJ. Borderline hypothyroidism and depression. Annu Rev Med 1995; 46: 37-46.
20. Hampel R, Kühlberg T, Klein K, et al. Strumaprävalenz in Deutschland größer als bisher angenommen. Med Klin 1995; 90: 324-9.
21. Hickie I, Bennett B, Mitchell P et al. Clinical and subclinical hypothyroidism in patients with chronic and treatment-resistant depression. Aust NZ J Psychiat 1996; 30: 246-52.
22. Joffe RT, Kutcher S, MacDonald C. Thyroid function and bipolar affective disorder. Psychiat Res 1988; 25: 117-21.
23. Kallner G, Petterson U. Renal, thyroid and parathyroid function during lithium treatment: laboratory tests in 207 people treated for 1-30 years. Acta Psychiat Scand 1995; 91: 48-51.
24. Koufen H, Consbruch U. Langzeitkatamnese zur Frage von Nutzen und Nebenwirkungen der Lithiumprophylaxe der phasischen Psychosen. Fortschr Neurol Psychiat 1989; 57: 374-82.
25. Kushner JP, Wartofsky L. Lithium-thyroid interactions. An overview. In: Lithium and the endocrine system. Lithium therapy monographs. Vol 2. Johnson FN (ed). Basel, München, Paris, London: Karger 1988; 74-98.
26. Lazarus JH, McGregor AM, Ludgate M et al. Effect of lithium carbonate therapy on thyroid immune status in manic depressive patients: A prospective study. J Affect Dis 1986; 11: 155-60.
27. Lazarus JH, Phillips DIW, Parkes AB et al. Status of iodine nutrition in the United Kingdom. In: Iodine deficiency in Europe. Delange F, Dunn JT, Glinoer D. (eds). New York, London: Plenum Press 1993; 323-7.
28. Lee S, Chow CC, Wing YK, Shek CC. Thyroid abnormalities during chronic lithium treatment in Hongkong Chinese: A controlled study. J Affect Dis 1992; 26: 173-8.
29. Lehmann K, Müller-Oerlinghausen B. Kosten/Nutzen-Kalkulation der Lithiumlangzeitprophylaxe. In: Ziele und Ergebnisse der medikamentösen Prophylaxe affektiver Psychosen. Müller-Oerlinghausen B, Berghofer A (Hrsg). Stuttgart, New York: Thieme 1994; 89-92.
30. Leutgeb U. Lithium und seine Wirkungen auf das Endokrinium, den Knochen und den peripheren Nerv - eine aktuelle Übersicht. Fortschr Neurol Psychiat 1995; 63: 149-61.
31. Lindstedt G, Nilsson L, Walinder J et al. On the prevalence, diagnosis and management of lithium-induced hypothyroidism in psychiatric patients. Brit J Psychiat 1977; 130: 452-8.
32. Lombardi G, Panza N, Biondi B et al. Effects of lithium treatment on hypothalamic-pituitary-thyroid axis: A longitudinal study. J Endocrinol Invest 1993; 16: 259-63.
33. Mackenroth T, Scriba PC. Krankheiten der Schilddrüse. In: Innere Medizin in Praxis und Klinik. Bd.I: Gefäße, Atmungsorgane, Endokrines System. Hornbostel H, Kaufmann W, Siegenthaler W (Hrsg). Stuttgart, New York: Thieme 1992; 4.22-4.68.
34. Männistö PT. Endocrine side-effects of lithium. In: Handbook of lithium therapy. Johnson FN (ed). Lancaster: MTP Press 1980; 310-22.
35. Mann K. Therapeutische Möglichkeiten und Risiken der Knotenstruma aus internistischer Sicht. In: Schilddrüse 1991. Therapie der Struma. Roher HD, Weinheimer B (Hrsg). Berlin, New York: W de Gruyter 1992; 138-44.
36. Martino E, Loviselli A, Velluzzi F et al. Endemic goiter and thyroid function in Central-Southern Sardinia: Report on an extensive epidemiological survey. J Endocrinol Invest 1994; 17: 653-7.
37. Martino E, Placidi GF, Sardano G et al. High incidence of goiter in patients treated with lithium carbonate. Ann Endocrinol (Paris) 1982; 43: 269-76.
38. McDermott MT, Burmann KD, Hofeldt FD, Kidd GS. Lithium-associated thyrotoxicosis. Am J Med 1986; 80: 1245-8.
39. Monzani F, Del Guerra P, Caraccio N et al. Subclinical hypothyroidism: Neurobehavioral features and beneficial effect of L-thyroxine treatment. Clin Investig 1993; 71: 367-71.
40. Müller N, Kapfhammer HP, Spatz R, Hippius H. Die Lithium-Prophylaxe: Hohe Effizienz und geringes Risiko bei regelmäßiger Überwachung. Dt Ärztebl 1995; 92: A-365-9.
41. Myers DH, Carter RA, Burns BH et al. A prospective study of the effects of lithium on thyroid function and on the prevalence of antithyroid antibodies. Psycholog Med 1985; 15: 55-61.
42. Nyström E, Caidahl K, Fager G et al. A double-blind cross-over 12-months study of L-thyroxine treatment of women with »subclinical« hypothyroidism. Clin Endocrinol 1988; 29: 63-76.
43. Olbricht T. Pathophysiologische Grundlagen für therapeutische Strategien. In: Schilddrüse 1991. Thérapie der Struma. Röher HD, Weinheimer B (Hrsg). Berlin, New York: W de Gruyter 1992; 3-12.
44. Perrild H, Hegedüs L, Baastrup PC et al. Thyroid function and ultrasonically determined thyroid size in patients receiving long-term lithium treatment. Am J Psychiat 1990; 147: 1518-21.
45. Prohaska ML, Stern RA, Nevels CT et al. The relationship between thyroid status and neuropsychological performance in psychiatric outpatients maintained on lithium. Neuropsychiat Neuropsychol Behav Neurol 1996; 9: 30-4.
46. Reinhardt W, Luster M, Rudorff KH et al. Effect of small doses of iodine on thyroid function in patients with Hashimoto's thyroiditis residing in an iodine deficient area. Abstract. 11.Int.Thyroid Congress, Toronto: 1995.
47. Reinwein D. Klinische Aspekte der subklinischen und manifesten Hypothyreose. In: Schilddrüse 1995. Schilddrüsenerkrankungen in verschiedenen Lebensabschnitten. Usadel KH, Weinheimer B (Hrsg). Berlin, New York: W de Gruyter 1996; 344-51.
48. Sadoul JL, Kezachian B, Freychet P. Thérapeutique par lithium et hyperthyroïdie: pathologie causée ou facilitée par le lithium? Ann Endocrinol (Paris) 1993; 54: 353-8.
49. Schaaf L, Pohl T, Schmidt R et al. Screening for thyroid disorders in a working population. Clin Investig 1993; 71: 126-31.
50. Schou M, Amdisen A, Jensen SE, Olsen T. Occurence of goitre during lithium treatment. Brit Med J 1968; 3: 710-3.
51. Scriba PC, Gärtner R, Heufelder AE. Kontroversen in der Behandlung benigner Schilddrüsenerkrankungen. Internist 1994; 35: 346-54.
52. Spaulding SW, Burrow GN, Ramey JN, Donabedian RK. Effect of increased iodide intake on thyroid function in subjects on chronic lithium therapy. Acta Endocrinol 1977; 84: 290-6.
53. Stover C, Kahaly G. Jodid vs. Levothyroxin bei Jodmangelstruma - eine Doppelblind-studie. In: Schilddrüse 1991.Therapie der Struma. Roher HD, Weinheimer B (Hrsg). Berlin, New York: W de Gruyter 1992; 94-5.
54. Stübner D, Gärtner R, Greil W, Cropper K. Hypertrophy and hyperplasia during goitre growth and involution in rats - separate bioeffects of TSH and iodine. Acta Endocrinol (Copenh) 1987; 116: 537-48.
55. Transbol I, Christiansen C, Baastrup PC. Endocrine effects of lithium. I. Hypothyroidism, its prevalence in long-term treated patients. Acta Endocrinol (Copenh) 1978; 87: 759-67.
56. Tsuchiya Y, Motoyasu A, Isozaki O et al. Effect of lithium on desoxyribonucleic acid synthesis and iodide uptake in porcine thyroid cells in culture. Endocrinol 1990; 126: 460-5.
57. Tunbridge WMG, Brewis M, French JM et al. Natural history of autoimmune thyroiditis. Brit Med J 1981; 282: 258-62.
58. Tunbridge WMG, Evered DC, Hall R et al. The spectrum of thyroid disease in a community: The Whickham Survey. Clin Endocrinol 1977; 7: 481-93.
59. Vanderpump MPJ, Tunbridge WMG, French JM et al. The incidence of thyroid disorders in the community: a twenty-year follow-up of the Whickham survey. Clin Endocrinol 1995; 43: 55-68.
60. Vincent A, Baruch P, Vincent P. Lithium-associated hypothyroidism: A practical review. Lithium 1994; 5: 73-4.
61. Wahl RA, Khan O, Labus M, Pfannenstiel P. Nachsorge nach chirurgischer Therapie. In: Schilddrüse 1991. Therapie der Struma. Roher HD, Weinheimer B (Hrsg). Berlin New York: W de Gruyter 1992; 287-99.
62. Wasilewski B, Steinböck H, Kohl R et al. Schilddrüsenfunktion bei der Lithiumprophylaxe. Arzneim-Forsch/Drug Res 1978; 28: 1297-8.
63. Weber E, Coche E. Hyperthyroïdie après arrêt du lithium: coïncidence ou non? Rev Méd Int 1995; 16: 437-9.
64. Weetman AP, McGregor AM, Lazarus JH et al. The enhancement of immunoglobulin synthesis by human lymphocytes with lithium. Clin Immunol Immunopathol 1982; 22: 400-7.
65. Wilson R, McKillop JH, Crocket GT et al. The effect of lithium therapy on parameters thought to be involved in the development of autoimmune thyroid disease. Clin Endocrinol 1991; 34: 357-61.
66. Wolff J. Lithium interactions with the thyroid gland. In: Lithium controversies and unresolved issues. Cooper TB, Gershon S, Kline NS, Schou M (eds). Amsterdam: Excerpta Medica 1979; 552-64.
67. Wolff J, Berens SC, Jones AB. Inhibition of thyrotropin-stimulated adenyl cyclase activity of beef thyroid membranes by low concentration of lithium ion. Biochem Biophys Res Commun 1970; 39: 77-82.
68. Yassa R, Saunders A, Nastase C, Camille Y. Lithium-induced thyroid disorders: A prevalence study. J Clin Psychiat 1988; 49: 14-6.